Advertisement

Rheumatology International

, Volume 35, Issue 1, pp 141–151 | Cite as

Convergence between the 1990 and 2010 ACR diagnostic criteria and validation of the Spanish version of the Fibromyalgia Survey Questionnaire (FSQ)

  • M. T. Carrillo-de-la-Peña
  • Y. Triñanes
  • A. González-Villar
  • S. Romero-Yuste
  • C. Gómez-Perretta
  • M. Arias
  • F. Wolfe
Original Article

Abstract

(1) To assess the degree of convergence between the 1990 and 2010 American College of Rheumatology (ACR) diagnostic criteria; (2) To evaluate the validity and reliability of the 2010 ACR criteria; (3) To validate the Spanish version of the Fibromyalgia Survey Questionnaire (FSQ); and (4) To assess the utility of the FSQ to differentiate fibromyalgia (FM) subgroups by disease severity. In the first study, agreement between the 1990 and 2010 ACR criteria for FM diagnosis was analyzed in a sample of 80 FM patients and 59 healthy controls. Algometry (mean threshold and tender points count) and the 2010 ACR indices [Symptom Severity Scale (SSS), Widespread Index (WPI) and Polysymptomatic Distress Scale (PSD)] were correlated with the key symptoms of FM and with indices of disease interference and quality of life. In a second study, we evaluated the validity and internal consistency of the Spanish version of the FSQ, as well as its ability to discriminate between groups of FM patients with low and high symptom severity. There is good agreement between the 1990 and 2010 ACR criteria for FM diagnosis. The 2010 ACR indices (SSS, WPI and PSD) demonstrated very adequate construct validity and appeared to be useful in the assessment of disease severity and global impact of FM. The FSQ had good internal consistency and validity and showed 100 % concordance with 2010 ACR criteria applied by a clinician. In addition, the FSQ proved to be useful in differentiating FM severity subgroups.

Keywords

Fibromyalgia American College of Rheumatology criteria Fibromyalgia Survey Questionnaire (FSQ) Symptom severity 

Notes

Acknowledgments

The authors thank Leonor Varela-Lema and Mabel Sampedro-Parada for their assistance in the back translation of the FSQ. This work was supported by the Spanish Ministry of Science and Innovation (ref PSI2009-14555).

References

  1. 1.
    Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL et al (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum 33:160–172PubMedCrossRefGoogle Scholar
  2. 2.
    Goldenberg DL (2009) Diagnosis and differential diagnosis of fibromyalgia. Am J Med 122(12 Suppl):S14–S21PubMedCrossRefGoogle Scholar
  3. 3.
    Wolfe F, Clauw D, Fitzcharles MA, Goldenberg D, Katz RS, Mease P et al (2010) The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res 62:600–610CrossRefGoogle Scholar
  4. 4.
    Wolfe F, Häuser W (2011) Fibromyalgia diagnosis and diagnostic criteria. Ann Med 43(7):495–502PubMedCrossRefGoogle Scholar
  5. 5.
    Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Häuser W, Katz RS et al (2011) Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol 38(6):1113–1122PubMedCrossRefGoogle Scholar
  6. 6.
    Häuser W, Jung E, Erbslöh-Möller B, Gesmann M, Kühn-Becker H, Petermann F et al (2012) Validation of the Fibromyalgia Survey Questionnaire within a cross-sectional survey. PLoS ONE 7(5):e37504PubMedCentralPubMedCrossRefGoogle Scholar
  7. 7.
    Fitzcharles MA, Ste-Marie PA, Panopalis P, Ménard H, Shir Y, Wolfe F (2012) The 2010 American college of rheumatology fibromyalgia survey diagnostic criteria and symptom severity scale is a valid and reliable tool in a French speaking fibromyalgia cohort. BMC Musculoskelet Disord 13:179PubMedCentralPubMedCrossRefGoogle Scholar
  8. 8.
    Ferrari R, Russell AS (2013) A questionnaire using the modified 2010 American College of Rheumatology criteria for fibromyalgia: specificity and sensitivity in clinical practice. J Rheumatol 40(9):1590–1595PubMedCrossRefGoogle Scholar
  9. 9.
    Usui C, Hatta K, Aratani S, Yagishita N, Nishioka K, Kanazawa T et al (2013) The Japanese version of the modified ACR Preliminary Diagnostic Criteria for Fibromyalgia and the Fibromyalgia Symptom Scale: reliability and validity. Mod Rheumatol 23(5):846–850PubMedCrossRefGoogle Scholar
  10. 10.
    Hilton A, Skrutkowski M (2002) Translating instruments into other languages: development and testing processes. Cancer Nurs 25(1):1–7PubMedCrossRefGoogle Scholar
  11. 11.
    Buysse DJ, Charles F, Reynolds TH, Berman SR, Kupfer DJ (1989) The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res 28(2):193–213PubMedCrossRefGoogle Scholar
  12. 12.
    Bennett R (2005) The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol 23(5 Suppl 39):S154–S162PubMedGoogle Scholar
  13. 13.
    Ware JE (2000) SF-36 health survey update. Spine 25:3130–3139PubMedCrossRefGoogle Scholar
  14. 14.
    Beck AT, Steer RA, Garbin MG (1988) Psychometric properties of the Beck Depression Inventory: twenty-five years of the valuation. Clin Psychol Rev 8:77–100CrossRefGoogle Scholar
  15. 15.
    Spielberger CD, Gorssuch RL, Lushene PR, Vagg PR, Jacobs GA (1983) Manual for the State-Trait Anxiety Inventory. Consulting Psychologists Press Inc., Palo AltoGoogle Scholar
  16. 16.
    Macías JA, Royuela R (1996) La versión española del Índice de Calidad de Sueño de Pittsburgh. Inf Psiquiátr 146:465–472Google Scholar
  17. 17.
    Monterde S, Salvata I, Montulla S, Fernández-Ballart J (2004) Validación de la versión española del Fibromyalgiam Impact Questionnaire. Rev Esp Reumatol 31(9):507–513Google Scholar
  18. 18.
    Alonso J, Prieto L, Antó JM (1995) The Spanish version of the SF-36 Health Survey (the SF-36 health questionnaire): an instrument for measuring clinical results. Med Clin 104:20771–20776Google Scholar
  19. 19.
    Sanz J, Vázquez C (1998) Fiabilidad, validez y datos normativos del Inventario para la Depresión de Beck. Psicothema 2:303–318Google Scholar
  20. 20.
    Seisdedos N (1988) Adaptación Española del STAI, Cuestionario de ansiedad estado-rasgo [Spanish adaptation of the STAI, State-Trait Anxiety Inventory]. TEA Ediciones, MadridGoogle Scholar
  21. 21.
    Triñanes Y, Gónzalez-Villar A, Gómez-Perretta C, Carrillo-de-la-Peña MT (2014) Suicidality in chronic pain: predictors of suicidal ideation in fibromyalgia. Pain Pract. doi: 10.1111/papr.12186 PubMedGoogle Scholar
  22. 22.
    Spitzer RL, Kroenke K, Williams JB (1999) Validation and utility of a selfreport version of PRIME-MD: the PHQ primary care study. Primary care evaluation of mental disorders. Patient Health Questionnaire. JAMA 282(18):1737–1744PubMedCrossRefGoogle Scholar
  23. 23.
    Kroenke K, Spitzer RL, Williams JB (2002) The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 64:258–266PubMedCrossRefGoogle Scholar
  24. 24.
    Ware J, Kosinski M, Keller SD (1996) A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 34(3):220–233PubMedCrossRefGoogle Scholar
  25. 25.
    Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE et al (1998) Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 13:1171–1178CrossRefGoogle Scholar
  26. 26.
    Landis J, Koch G (1977) The measurement of observer agreement for categorical data. Biometrics 33(1):159PubMedCrossRefGoogle Scholar
  27. 27.
    Kim SM, Lee SH, Kim HR (2012) Applying the ACR preliminary diagnostic criteria in the diagnosis and assessment of fibromyalgia. Korean J Pain 25(3):173–182PubMedCentralPubMedCrossRefGoogle Scholar
  28. 28.
    Wolfe F (1997) The relation between tender points and fibromyalgia symptom variables: evidence that fibromyalgia is not a discrete disorder in the clinic. Ann Rheum Dis 56(4):268–271PubMedCentralPubMedCrossRefGoogle Scholar
  29. 29.
    Harth M, Nielson WR (2007) The fibromyalgia tender points: use them or lose them? A brief review of the controversy. J Rheumatol 34(5):914–922PubMedGoogle Scholar
  30. 30.
    Wolfe F, Brähler E, Hinz A, Häuser W (2013) Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population. Arthritis Care Res 65(5):777–785CrossRefGoogle Scholar
  31. 31.
    Buskila D, Neumann L (1997) Fibromyalgia syndrome (FM) and nonarticular tenderness in relatives of patients with FM. J Rheumatol 24(5):941–944PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • M. T. Carrillo-de-la-Peña
    • 1
  • Y. Triñanes
    • 1
  • A. González-Villar
    • 1
  • S. Romero-Yuste
    • 2
  • C. Gómez-Perretta
    • 3
  • M. Arias
    • 4
  • F. Wolfe
    • 5
    • 6
  1. 1.Department of Clinical Psychology and PsychobiologyUniversity of Santiago de CompostelaSantiago de CompostelaSpain
  2. 2.Rheumatology ServiceHospital of PontevedraPontevedraSpain
  3. 3.Research Foundation of La Fe HospitalValenciaSpain
  4. 4.Neurology ServiceUniversitary Hospital of Santiago de CompostelaSantiago de CompostelaSpain
  5. 5.National Data Bank for Rheumatic DiseasesWichitaUSA
  6. 6.University of Kansas School of MedicineWichitaUSA

Personalised recommendations